15 articles for H Ishida
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
A Novel Potent and Highly Specific Inhibitor against Influenza Viral N1-N9 Neuraminidases: Insight into Neuraminidase-Inhibitor Interactions.
Thammasat University
Interaction kinetics of liposome-incorporated unsaturated fatty acids with fatty acid-binding protein 3 by surface plasmon resonance.
Osaka University
Potent small molecule mouse CD22-inhibitors: exploring the interaction of the residue at C-2 of sialic acid scaffold.
Gifu University
Studies on selectin blocker. 1. Structure-activity relationships of sialyl Lewis X analogs.
Institute of Cancer Research
Studies on selectin blockers. 2. Novel selectin blocker as potential therapeutics for inflammatory disorders.
New Drug Research Laboratory
CD22-antagonists with nanomolar potency: the synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold.
Gifu University
Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids.
Gifu University
Design, synthesis, and structure-affinity relationships of novel series of sialosides as CD22-specific inhibitors.
Gifu University
Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitors.
Kyowa Hakko Kogyo
Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
Gifu University
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds.
Daiichi Pharmaceutical
Lithocholic Acid Derivatives as Potent Vitamin D Receptor Agonists.
Ochanomizu University
Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer.
Kyowa Hakko Kogyo
Vitamin D Analogues with a p-Hydroxyphenyl Group at the C25 Position: Crystal Structure of Vitamin D Receptor Ligand-Binding Domain Complexed with the Ligand Explains the Mechanism Underlying Full Antagonistic Action.
Showa Pharmaceutical University
